Sakai D, Kadowaki S, Kawabata R, Hara H, et al. Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial. J Clin Oncol 2025 May 23:JCO2401119. doi: 10.1200/JCO.24.01119.
PMID: 40408613